Gilead study says remdesivir reduces the risk of death in severely ill coronavirus patients
Gilead study says remdesivir reduces the risk of death in severely ill coronavirus patients by 62% Gilead compared 312 severely ill coronavirus patients receiving remdesivir compared to 818 patients receiving standard of care Nearly 75% of those treated with remdesivir recovered compared to 59% not given the drug Only 7.6% of remdesivir-treated patients died compared to … Read more